On behalf of the Editorial board I invite you to submit your next article to Translational Oncogenomics, an open access electronic journal published by Libertas Academica. The journal specializes in providing wide and open access for high quality genomic scale data related to human cancer etiology, detection, prognosis and treatment. We accept original studies in basic and applied oncogenomics and thoughtful reviews, surveys, opinions, commentaries, techniques, and essays. All submitted articles will be considered and peer-reviewed.

We look forward to receiving your manuscript.

What is the advantage to you of publishing in Translational Oncogenomics?

Full open access: everyone can read your article and you retain copyright in it
Publishing decision within 2 weeks of submission
Your paper will not be rejected due to lack of space and will be published immediately on acceptance
Prompt and fair peer review from two expert peer reviewers
Frequent updates on your paper’s status
Friendly responsive staff

What a previous author said:

"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."

In summary:

The advantages of a younger journal such as Translational Oncogenomics are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.

Timing and deadlines:

Submissions are welcomed at any time. Papers are published on an on-going basis.

Next steps:

** Click on the link for further information **

Yours sincerely,

Dr Michael Spinella

Editor-in-Chief
Translational Oncogenomics